Advertisement
DYAI Notícias Sobre o Forex
Dyadic Int'l Collaborates With France's BYoRNA To Produce Abundant, Low-Cost MRNA From C1-Cells
Biotechnology companies Dyadic International, Inc. (DYAI) and France's bYoRNA SAS announced Tuesday that they entered into a development and commercialization agreement to work on disruptive bio-production technologies that will help exploit the therapeutic potential of messenger RNA (mRNA).
RTTNews
|
674 dias atrás
